|
Status |
Public on Jan 01, 2012 |
Title |
Expression data from docetaxel-resistant prostate cancer cell lines |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Docetaxel-based chemotherapy is the standard first-line therapy in metastatic castration-resistant prostate cancer. However, most patients eventually develop resistance to this treatment. The aim of the study was to identify key molecular genes and networks associated with docetaxel resistance in 2 models of docetaxel-resistant castration-resistant prostate cancer cell lines.
|
|
|
Overall design |
DU-145 and PC-3 cells were converted to docetaxel-resistant cells, DU-145R and PC-3R, respectively. Whole-genome arrays were used to compare global gene expression between these 4 cell lines. Arrays were performed by triplicate for each cell line.
|
|
|
Contributor(s) |
Marín-Aguilera M, Kalko SG, Mellado B |
Citation(s) |
22027694 |
|
Submission date |
Nov 03, 2011 |
Last update date |
Mar 12, 2020 |
Contact name |
Mercedes Marín-Aguilera |
E-mail(s) |
[email protected]
|
Organization name |
Fundació Clínic per a la Recerca Biomèdica
|
Street address |
Villarroel 170
|
City |
Barcelona |
ZIP/Postal code |
08036 |
Country |
Spain |
|
|
Platforms (1) |
GPL570 |
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array |
|
Samples (12)
|
|
Relations |
Affiliated with |
GSE67157 |
BioProject |
PRJNA148679 |